Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension

Journal:

American Journal of Respiratory and Critical Care Medicine

Published:

2026-04-01

DOI:

10.1093/ajrccm/aamaf128

Affiliations:

25

Authors:

25

Go to article

Institutions	Authors	Share
JadeBio Inc., United States of America (USA)	6.000000	0.24
Tufts Medical Center, United States of America (USA)	1.000000	0.04
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.04
Summit Health, United States of America (USA)	1.000000	0.04
Guangdong Cardiovascular Institute, China	1.000000	0.04
Michigan Medicine, U-M, United States of America (USA)	1.000000	0.04
University of Cologne (UoC), Germany	1.000000	0.04
IRCCS Policlinico San Matteo, Italy	1.000000	0.04
The George Washington University (GW), United States of America (USA)	1.000000	0.04
Arizona Pulmonary Specialists, Ltd., United States of America (USA)	1.000000	0.04
Sir Mortimer B. Davis Jewish General Hospital (SMBD JGH), Canada	1.000000	0.04
Favaloro Foundation, Argentina	1.000000	0.04
Unidad de Investigacion Clinica en Medicina, Mexico	1.000000	0.04
The University of Arizona (Arizona), United States of America (USA)	1.000000	0.04
Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies, France	1.000000	0.04
ERN LUNG, France, France	1.000000	0.04
Riga Stradiņš University (RSU), Latvia	1.000000	0.04
Hannover Medical School (MHH), Germany	0.500000	0.02
Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Germany	0.500000	0.02
Krakow Specialist Hospital Saint John Paul II, Poland	0.500000	0.02
Jagiellonian University (UJ), Poland	0.500000	0.02
Biomedical Research Networking Centers (CIBER), Spain	0.250000	0.01
Hospital Universitario 12 de Octubre, Spain	0.250000	0.01
ERN LUNG, Spain, Spain	0.250000	0.01
Complutense University of Madrid (UCM), Spain	0.250000	0.01

Interested in Cardiovascular Medicine and Haematology?